These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37836794)

  • 1. Novel 1,2,3-Triazole-Containing Quinoline-Benzimidazole Hybrids: Synthesis, Antiproliferative Activity, In Silico ADME Predictions, and Docking.
    Krstulović L; Mišković Špoljarić K; Rastija V; Filipović N; Bajić M; Glavaš-Obrovac L
    Molecules; 2023 Oct; 28(19):. PubMed ID: 37836794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel 7-Chloro-4-aminoquinoline-benzimidazole Hybrids as Inhibitors of Cancer Cells Growth: Synthesis, Antiproliferative Activity, in Silico ADME Predictions, and Docking.
    Krstulović L; Leventić M; Rastija V; Starčević K; Jirouš M; Janić I; Karnaš M; Lasić K; Bajić M; Glavaš-Obrovac L
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis, Antitumor, and Antiplasmodial Evaluation of New 7-Chloroquinoline-Benzimidazole Hybrids.
    Krstulović L; Rastija V; Pessanha de Carvalho L; Held J; Rajić Z; Živković Z; Bajić M; Glavaš-Obrovac L
    Molecules; 2024 Jun; 29(13):. PubMed ID: 38998949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, characterization, in vitro antimycobacterial and cytotoxicity evaluation, DFT calculations, molecular docking and ADME studies of new isomeric benzimidazole-1,2,3-triazole-quinoline hybrid mixtures.
    Nyoni NTP; Ncube NB; Kubheka MX; Mkhwanazi NP; Senzani S; Singh T; Tukulula M
    Bioorg Chem; 2023 Dec; 141():106904. PubMed ID: 37832224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New 3-(1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one-based triazole derivatives: Design, synthesis, and biological evaluation as antiproliferative and apoptosis-inducing agents.
    Gaikwad NB; Bansode S; Biradar S; Ban M; Srinivas N; Godugu C; Yaddanapudi VM
    Arch Pharm (Weinheim); 2021 Nov; 354(11):e2100074. PubMed ID: 34346099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of radioiodinated benzo[d]imidazole-quinoline derivatives for platelet-derived growth factor receptor β (PDGFRβ) imaging.
    Effendi N; Mishiro K; Takarada T; Yamada D; Nishii R; Shiba K; Kinuya S; Odani A; Ogawa K
    Bioorg Med Chem; 2019 Jan; 27(2):383-393. PubMed ID: 30563725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis.
    Nandikolla A; Srinivasarao S; Khetmalis YM; Kumar BK; Murugesan S; Shetye G; Ma R; Franzblau SG; Sekhar KVGC
    Toxicol In Vitro; 2021 Aug; 74():105137. PubMed ID: 33684466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of New Benzimidazole-1,2,3-triazole Hybrids as Tyrosinase Inhibitors.
    Mahdavi M; Ashtari A; Khoshneviszadeh M; Ranjbar S; Dehghani A; Akbarzadeh T; Larijani B; Khoshneviszadeh M; Saeedi M
    Chem Biodivers; 2018 Jul; 15(7):e1800120. PubMed ID: 29766648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A concise and efficient synthesis of amino-substituted (1H-benzo[d]imidazol-1-yl)pyrimidine hybrids: synthetic sequence and the molecular and supramolecular structures of six examples.
    Vicentes DE; Rodríguez R; Ochoa P; Cobo J; Glidewell C
    Acta Crystallogr C Struct Chem; 2019 Oct; 75(Pt 10):1405-1416. PubMed ID: 31589157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and ADMET prediction of bis-benzimidazole as anticancer agent.
    Rashid M
    Bioorg Chem; 2020 Mar; 96():103576. PubMed ID: 31986463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of 1,2,3-triazole based 2-aminobenzimidazoles as novel inhibitors of LasR dependent quorum sensing in
    Srinivasarao S; Nandikolla A; Nizalapur S; Yu TT; Pulya S; Ghosh B; Murugesan S; Kumar N; Chandra Sekhar KVG
    RSC Adv; 2019 Sep; 9(50):29273-29292. PubMed ID: 35528444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, Docking, and Machine Learning Studies of Some Novel Quinolinesulfonamides-Triazole Hybrids with Anticancer Activity.
    Marciniec K; Nowakowska J; Chrobak E; Bębenek E; Latocha M
    Molecules; 2024 Jul; 29(13):. PubMed ID: 38999109
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Kumar S; Ali I; Abbas F; Rana A; Pandey S; Garg M; Kumar D
    J Biomol Struct Dyn; 2024 Nov; 42(18):9416-9438. PubMed ID: 37646177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 1H-1,2,3-Triazole-Linked Quinoline-Isatin Molecular Hybrids as Anti-Breast Cancer and Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents.
    Awolade P; Cele N; Ebenezer O; Kerru N; Gummidi L; Gu L; Palma G; Kaur M; Singh P
    Anticancer Agents Med Chem; 2021; 21(10):1228-1239. PubMed ID: 32990543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and cytotoxicity evaluation of some novel thiazoles, thiadiazoles, and pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-5(1H)-ones incorporating triazole moiety.
    Gomha SM; Ahmed SA; Abdelhamid AO
    Molecules; 2015 Jan; 20(1):1357-76. PubMed ID: 25594346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, characterization, and molecular docking analysis of novel benzimidazole derivatives as cholinesterase inhibitors.
    Yoon YK; Ali MA; Wei AC; Choon TS; Khaw KY; Murugaiyah V; Osman H; Masand VH
    Bioorg Chem; 2013 Aug; 49():33-9. PubMed ID: 23886696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, ADME prediction and pharmacological evaluation of novel benzimidazole-1,2,3-triazole-sulfonamide hybrids as antimicrobial and antiproliferative agents.
    Al-Blewi FF; Almehmadi MA; Aouad MR; Bardaweel SK; Sahu PK; Messali M; Rezki N; El Ashry ESH
    Chem Cent J; 2018 Nov; 12(1):110. PubMed ID: 30387018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitors.
    Shi L; Wu TT; Wang Z; Xue JY; Xu YG
    Eur J Med Chem; 2014 Sep; 84():698-707. PubMed ID: 25064347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of 3-substituted-6-(1-(1H-[1,2,3]triazolo[4,5-b]pyrazin-1-yl)ethyl)quinoline derivatives as highly potent and selective mesenchymal-epithelial transition factor (c-Met) inhibitors via metabolite profiling-based structural optimization.
    Zhao F; Zhang LD; Hao Y; Chen N; Bai R; Wang YJ; Zhang CC; Li GS; Hao LJ; Shi C; Zhang J; Mao Y; Fan Y; Xia GX; Yu JX; Liu YJ
    Eur J Med Chem; 2017 Jul; 134():147-158. PubMed ID: 28411455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, Biological Evaluation and In Silico Computational Studies of 7-Chloro-4-(1
    Rosado-Solano DN; Barón-Rodríguez MA; Sanabria Florez PL; Luna-Parada LK; Puerto-Galvis CE; Zorro-González AF; Kouznetsov VV; Vargas-Méndez LY
    J Agric Food Chem; 2019 Aug; 67(33):9210-9219. PubMed ID: 31390203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.